Follow the Shanghai Bio-heart Biological Technology Co., Ltd. - B share price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Shanghai Bio-heart Biological Technology Co., Ltd. - B has published 21 reports. Market capitalisation: €555m. The latest transaction was reported on 15 May 2026 (Purchase). Among the most active insiders: Wang Philip Li. All data is free.
21
Insider Decl.
n/a
Thresholds
€99,815
21 ops.
Buy Volume
n/a
n/a
Sell Volume
14Σ signal
Buys €99,815n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,218 of 29,055 companies
25.1
score / 100
Value
12
Quality
38
FCF yld-16%
Earn yld-15%
EV/EBITDA·
ROE-11%
Gross mgn40%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.